We help doctors and pharma companies evaluate cancer drug efficacy using patient microtumors and computer vision
At Pear Bio, we monitor cancer progression of patient-derived tumor samples against potential treatment options. Our microtumor technology recreates core parts of the human tumor microenvironment for accurate lab testing. With the aid of our computer vision algorithms, we measure the impact each treatment has on stopping cancer in its tracks and eliminating the tumor. We can inform physicians on treatment decisions and we provide tools to help pharmaceutical companies develop new therapies. We also analyze tumor samples to identify promising targets for developing new anti-cancer treatments.
Which of the following applies to you?
Personalized Cancer Medicine
A doctor is facing multiple approved treatments and needs help to narrow down the options for a cancer patient.
Clinical Trials
A cancer patient won’t benefit from existing approved treatments and needs to find an experimental drug for a chance of survival.
Pharma Research & Development
A pharma company wants to weed out unpromising cancer drug candidates in the preclinical phase and save money.
